ISHARES DOW JONES US PHARMACEUTICALS: (AMEX: IHE)
$102.26
0.91 (0.90%)
Volume 25,181
May 21 03:59 PM ET
| Previous Close | 101.35 |
| Open | 101.93 |
| Bid | 101.69 |
| Ask | 102.59 |
| Day Low-High | 100.90-102.33 |
| 52wk Low-High | 79.15-103.42 |
| Avg Volume | 25,181 |
| NAV | 99.11 |
| Premium | +2.24 |
| Expense Ratio | 0.46% |
| Dividend (Yield) | $1.68 (1.65%) |
| Issuer | BLACKROCK |
| IHE External Home Page >> | |
BENCHMARK for IHE
DOW JONES US SELECT PHARMACEUTICALS
This Index is a subset of the Dow Jones U.S. Pharmaceuticals and Biotechnology Index which is a free-float adjusted market capitalization-weighted index.The Index measures the performance of the pharmaceuticals sector of the U.S. equity market.The Index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
FUND SUMMARY FOR IHE
ISHARES DOW JONES US PHARMACEUTICALS
The iShares Dow Jones U.S. Pharmaceuticals Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Pharmaceuticals Index.
Zacks ETF Rank : IHE
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Zacks Commentary For IHE
Zacks Blog: Is This Low Risk Pharma ETF a Great Pick?
Oct, 09 2012
Zacks Blog: What Patent Cliff? Pharma ETFs Continue to Surge
Jul, 10 2012
News For IHE
This Dead Money Sector is Leading the S&P This Year - Benzinga
Mar 25, 2013
TNH, KTP, GJD, ACOR, IHE, XPH Are Seasonally Ripe To Go Up In the Next Five Weeks - Comtex
Dec 5, 2012
SBH, MRH, IHE Are Seasonally Ripe To Go Up In the Next Five Weeks - Comtex
Nov 7, 2012
BUYINS.NET: PMC, PKB, IHE, QLD Are Seasonally Ripe To Go Up In the Next Five Weeks - Comtex
Sep 5, 2012
